{"transactions":[{"id":699416,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":116944,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699415,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":false,"shares":11769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":164776,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11769},"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699414,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3326,"price":0.5,"value":1663.0,"ownership":{"direct":true},"balance_after":241173,"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699413,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":244499,"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699412,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3348,"price":0.5,"value":1674.0,"ownership":{"direct":true},"balance_after":232805,"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":699411,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-03T14:59:50.000Z","date":"2026-07-30","kind":"exercise","planned":false,"acquired":true,"shares":11769,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":236153,"source":{"system":"sec-edgar","filing":"0001193125-26-329804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526329804/ownership.xml","form_type":"4"}},{"id":706063,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-20T20:10:13.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":23246,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-26-308922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308922/ownership.xml","form_type":"4"}},{"id":706062,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-07-20T20:10:13.000Z","date":"2026-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1101,"price":0.47,"value":517.47,"ownership":{"direct":true},"balance_after":224384,"source":{"system":"sec-edgar","filing":"0001193125-26-308922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308922/ownership.xml","form_type":"4"}},{"id":706061,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-07-20T20:10:13.000Z","date":"2026-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":225485,"source":{"system":"sec-edgar","filing":"0001193125-26-308922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526308922/ownership.xml","form_type":"4"}},{"id":747065,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-08T14:27:48.000Z","date":"2026-06-06","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001193125-26-260931","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526260931/ownership.xml","form_type":"4"}},{"id":747064,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-06-08T14:27:48.000Z","date":"2026-06-06","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":221611,"source":{"system":"sec-edgar","filing":"0001193125-26-260931","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526260931/ownership.xml","form_type":"4"}},{"id":794654,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T16:35:23.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant."}],"balance_after":176545,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11770},"source":{"system":"sec-edgar","filing":"0001193125-26-203344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203344/ownership.xml","form_type":"4"}},{"id":794653,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-04T16:35:23.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":128638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-26-203344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203344/ownership.xml","form_type":"4"}},{"id":794652,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-04T16:35:23.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11770,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":209111,"source":{"system":"sec-edgar","filing":"0001193125-26-203344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203344/ownership.xml","form_type":"4"}},{"id":794651,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-05-04T16:35:23.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":197341,"source":{"system":"sec-edgar","filing":"0001193125-26-203344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526203344/ownership.xml","form_type":"4"}},{"id":804003,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-21T15:15:26.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":27120,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-26-165591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165591/ownership.xml","form_type":"4"}},{"id":804002,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-21T15:15:26.000Z","date":"2026-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":185647,"source":{"system":"sec-edgar","filing":"0001193125-26-165591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526165591/ownership.xml","form_type":"4"}},{"id":923408,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-03T15:00:05.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":188314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Performance stock units (\"PSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 30, 2026, the Reporting Person was granted 188,314 PSUs which vest upon the following time-based vesting schedule: the PSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant, subject to satisfaction of the milestone-based vesting condition: the applicable percentage of the PSUs vesting based on a net product sales revenue target for the fiscal year ending December 31, 2026 as reported in the Issuer's Form 10-K. The full amount of the PSUs granted to the Reporting Person is reflected herein."}],"balance_after":188314,"derivative":{"underlying":"Common Stock","underlying_shares":188314},"source":{"system":"sec-edgar","filing":"0001193125-26-034627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034627/ownership.xml","form_type":"4"}},{"id":923407,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T15:00:05.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":188315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 30, 2026 (the \"Date of Grant\"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. The full amount of the RSUs granted to the Reporting Person is reflected herein."}],"balance_after":188315,"derivative":{"underlying":"Common Stock","underlying_shares":188315},"source":{"system":"sec-edgar","filing":"0001193125-26-034627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034627/ownership.xml","form_type":"4"}},{"id":923400,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T13:30:07.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":11695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":140332,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11695},"source":{"system":"sec-edgar","filing":"0001193125-26-034491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034491/ownership.xml","form_type":"4"}},{"id":923399,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-03T13:30:07.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":11695,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":181773,"source":{"system":"sec-edgar","filing":"0001193125-26-034491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526034491/ownership.xml","form_type":"4"}},{"id":936492,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T20:00:19.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":false,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":30994,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0001193125-26-016451","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016451/ownership.xml","form_type":"4"}},{"id":936491,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-20T20:00:19.000Z","date":"2026-01-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":170078,"source":{"system":"sec-edgar","filing":"0001193125-26-016451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526016451/ownership.xml","form_type":"4"}},{"id":1005711,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":3750,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005710,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.892,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005709,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":2250,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005708,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005707,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":2000,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005706,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005705,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1500,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005704,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005703,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1250,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005702,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005701,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1250,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005700,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005699,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":400,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005698,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005697,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1250,"derivative":{"exercise_price":1.95,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1005696,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-07T02:45:04.000Z","date":"2025-11-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 4, 2025, the Issuer's Board of Directors approved an option repricing, effective as of November 4, 2025, reducing the exercise price to $1.95 per share, the closing price of the Issuer's common stock on November 3, 2025. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.8,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001493152-25-021143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315225021143/ownership.xml","form_type":"4"}},{"id":1008963,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-04T17:35:32.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":152027,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0001193125-25-264044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264044/ownership.xml","form_type":"4"}},{"id":1008962,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-11-04T17:35:32.000Z","date":"2025-10-31","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":166203,"source":{"system":"sec-edgar","filing":"0001193125-25-264044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525264044/ownership.xml","form_type":"4"}},{"id":1015583,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-21T15:56:25.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":34869,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001193125-25-244582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244582/ownership.xml","form_type":"4"}},{"id":1015582,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-10-21T15:56:25.000Z","date":"2025-10-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":154509,"source":{"system":"sec-edgar","filing":"0001193125-25-244582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000119312525244582/ownership.xml","form_type":"4"}},{"id":1077026,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-04T21:29:48.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":false,"shares":11695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":163721,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11695},"source":{"system":"sec-edgar","filing":"0000950170-25-102161","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025102161/ownership.xml","form_type":"4"}},{"id":1077025,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-08-04T21:29:48.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":true,"shares":11695,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":150635,"source":{"system":"sec-edgar","filing":"0000950170-25-102161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025102161/ownership.xml","form_type":"4"}},{"id":1083665,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-07-22T16:43:39.000Z","date":"2025-07-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":38743,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0000950170-25-097503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025097503/ownership.xml","form_type":"4"}},{"id":1083664,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-07-22T16:43:39.000Z","date":"2025-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":138940,"source":{"system":"sec-edgar","filing":"0000950170-25-097503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025097503/ownership.xml","form_type":"4"}},{"id":1118906,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-09T23:54:11.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-084006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025084006/ownership.xml","form_type":"4"}},{"id":1118905,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-06-09T23:54:11.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":135066,"source":{"system":"sec-edgar","filing":"0000950170-25-084006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025084006/ownership.xml","form_type":"4"}},{"id":1161888,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-03T00:41:15.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":false,"shares":11694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":175416,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11694},"source":{"system":"sec-edgar","filing":"0000950170-25-063065","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025063065/ownership.xml","form_type":"4"}},{"id":1161887,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-05-03T00:41:15.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":true,"shares":11694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":122566,"source":{"system":"sec-edgar","filing":"0000950170-25-063065","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025063065/ownership.xml","form_type":"4"}},{"id":1168005,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-22T14:08:28.000Z","date":"2025-04-19","kind":"exercise","planned":false,"acquired":false,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":42617,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0000950170-25-056495","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025056495/ownership.xml","form_type":"4"}},{"id":1168004,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-04-22T14:08:28.000Z","date":"2025-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":110872,"source":{"system":"sec-edgar","filing":"0000950170-25-056495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025056495/ownership.xml","form_type":"4"}},{"id":1188750,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-03-28T21:12:54.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2025, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":75000,"derivative":{"exercise_price":0.2946,"expiration_date":"2035-03-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001641172-25-001279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000164117225001279/ownership.xml","form_type":"4"}},{"id":1286296,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T17:44:33.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":187110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025)."}],"balance_after":187110,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":187110},"source":{"system":"sec-edgar","filing":"0000950170-25-013045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013045/ownership.xml","form_type":"4"}},{"id":1286295,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-04T17:44:33.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":374220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025)."}],"balance_after":374220,"derivative":{"exercise_price":1.7,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":374220},"source":{"system":"sec-edgar","filing":"0000950170-25-013045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025013045/ownership.xml","form_type":"4"}},{"id":1298290,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-22T14:15:41.000Z","date":"2025-01-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":46492,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0000950170-25-007549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025007549/ownership.xml","form_type":"4"}},{"id":1298289,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-01-22T14:15:41.000Z","date":"2025-01-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":106997,"source":{"system":"sec-edgar","filing":"0000950170-25-007549","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017025007549/ownership.xml","form_type":"4"}},{"id":1350802,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350801,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.53,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350800,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350799,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.28,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350798,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350797,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.87,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350796,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350795,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.45,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350794,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350793,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.32,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350792,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":8000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350791,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.8,"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350790,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.54,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1350789,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-11-27T02:52:40.000Z","date":"2024-11-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the \"Effective Date\") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the \"|2013 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.25,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-047882","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224047882/ownership.xml","form_type":"4"}},{"id":1383784,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-10-21T19:53:19.000Z","date":"2024-10-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":50366,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0000950170-24-115925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024115925/ownership.xml","form_type":"4"}},{"id":1383783,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-10-21T19:53:19.000Z","date":"2024-10-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":103123,"source":{"system":"sec-edgar","filing":"0000950170-24-115925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024115925/ownership.xml","form_type":"4"}},{"id":1450771,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-07-22T13:44:15.000Z","date":"2024-07-19","kind":"exercise","planned":false,"acquired":false,"shares":3875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":54240,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3875},"source":{"system":"sec-edgar","filing":"0000950170-24-085092","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024085092/ownership.xml","form_type":"4"}},{"id":1450770,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-07-22T13:44:15.000Z","date":"2024-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":99249,"source":{"system":"sec-edgar","filing":"0000950170-24-085092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024085092/ownership.xml","form_type":"4"}},{"id":1487696,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-07T13:34:07.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":37500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-070250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024070250/ownership.xml","form_type":"4"}},{"id":1487695,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-06-07T13:34:07.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":95374,"source":{"system":"sec-edgar","filing":"0000950170-24-070250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024070250/ownership.xml","form_type":"4"}},{"id":1538663,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-19T21:02:52.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":58115,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0000950170-24-046085","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024046085/ownership.xml","form_type":"4"}},{"id":1538662,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-04-19T21:02:52.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":3874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":82874,"source":{"system":"sec-edgar","filing":"0000950170-24-046085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000095017024046085/ownership.xml","form_type":"4"}},{"id":1564706,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-22T01:01:01.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2024, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":45000,"derivative":{"exercise_price":1.53,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-24-010870","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315224010870/ownership.xml","form_type":"4"}},{"id":1675830,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-20T02:01:10.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":61989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024)."}],"balance_after":61989,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":61989},"source":{"system":"sec-edgar","filing":"0001209191-24-001976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001976/doc4.xml","form_type":"4"}},{"id":1675829,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-20T02:01:10.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":371935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (01/19/2024)."}],"balance_after":371935,"derivative":{"exercise_price":2.09,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":371935},"source":{"system":"sec-edgar","filing":"0001209191-24-001976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919124001976/doc4.xml","form_type":"4"}},{"id":1733656,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-11-21T17:19:26.000Z","date":"2023-11-17","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.09,"value":27250.0,"ownership":{"direct":true},"balance_after":79000,"source":{"system":"sec-edgar","filing":"0001209191-23-056198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123056198/doc4.xml","form_type":"4"}},{"id":1735445,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-11-20T15:07:28.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.9399,"value":46995.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of purchase prices paid was $0.9348 to $0.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001209191-23-055948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123055948/doc4.xml","form_type":"4"}},{"id":1932170,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-03T20:15:21.000Z","date":"2023-03-31","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.67,"value":33350.0,"ownership":{"direct":true},"balance_after":14855,"source":{"system":"sec-edgar","filing":"0001493152-23-010620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315223010620/ownership.xml","form_type":"4"}},{"id":1933848,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-31T20:15:38.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2023, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":40000,"derivative":{"exercise_price":6.28,"expiration_date":"2033-03-28","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-010275","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315223010275/ownership.xml","form_type":"4"}},{"id":1944292,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-20T20:05:44.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.46,"value":32300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.42 to $6.49, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":9855,"source":{"system":"sec-edgar","filing":"0001493152-23-008243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315223008243/ownership.xml","form_type":"4"}},{"id":2217046,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Performance Stock Options (right to buy)","published_at":"2022-07-01T20:49:50.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting person was granted a performance-based stock option on February 17, 2021, to purchase 60,000 shares of common stock. The option vests based on the attainment of established performance criteria related to the timing and successful results of the Company's Phase 2b/3 PRISM trial of Haduvio (nalbuphine ER) for the treatment of prurigo nodularis, and Phase 2 CANAL trial of Haduvio for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis. On June 29, 2022, the Compensation Committee of the Board of Directors of the Issuer certified that certain performance metrics related to the successful results of the PRISM trial were satisfied, resulting in the vesting of the option as to 48,000 shares of common stock. The performance-based option remains eligible for vesting with respect to the remaining shares of common stock underlying the option in the event that additional performance metrics related to the successful results of the CANAL trial are satisfied."}],"balance_after":48000,"derivative":{"exercise_price":3.21,"exercise_date":"2022-06-29","expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001209191-22-040287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000120919122040287/doc4.xml","form_type":"4"}},{"id":2217044,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T20:43:43.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":137500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 11, 2022. The 137,500 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 11, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment to the Form 4 originally filed for the reporting person on February 15, 2022 is being filed solely to attach the power of attorney exhibit that was inadvertently excluded from the original filing."}],"balance_after":137500,"derivative":{"exercise_price":0.511,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":137500},"source":{"system":"sec-edgar","filing":"0001209191-22-040273","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000120919122040273/doc4a.xml","form_type":"4/A","original_submission_date":"2022-02-15"}},{"id":2347485,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T13:33:21.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2022, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":30000,"derivative":{"exercise_price":6.87,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-22-006151","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315222006151/ownership.xml","form_type":"4"}},{"id":2394217,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-15T21:00:14.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":137500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 11, 2022. The 137,500 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 11, 2023 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026."}],"balance_after":137500,"derivative":{"exercise_price":0.511,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":137500},"source":{"system":"sec-edgar","filing":"0001209191-22-009734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000120919122009734/doc4.xml","form_type":"4"}},{"id":2802895,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-09T01:02:18.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares of common stock underlying the option on December 31, 2021, with the remainder vesting in equal annual installments on December 31 of each of the three ensuing years thereafter until vested in full."}],"balance_after":25000,"derivative":{"exercise_price":5.45,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-21-005627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315221005627/ownership.xml","form_type":"4"}},{"id":2881362,"issuer":{"id":4387,"kind":"organization","name":"Trevi Therapeutics, Inc.","symbol":"TRVI"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-03T21:20:14.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 1, 2021. The 200,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 1, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter, through February 1, 2025."}],"balance_after":200000,"derivative":{"exercise_price":3.03,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-21-004682","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000089924321004682/doc4.xml","form_type":"4"}},{"id":3369782,"issuer":{"id":8379,"kind":"organization","name":"Beyond Air, Inc.","symbol":"XAIR"},"owners":[{"id":27348,"kind":"person","name":"Forbes William P","position":1,"cik":"0001314760","reported_name":"Forbes William P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-15T21:30:31.000Z","date":"2019-06-03","kind":"purchase","acquired":true,"shares":4855,"price":5.15,"value":25003.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Closing price of common stock on May 31, 2019."}],"balance_after":4855,"source":{"system":"sec-edgar","filing":"0001493152-19-017756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314760/000149315219017756/ownership.xml","form_type":"4"}}]}